Drug & medication recalls Moderate risk

Teva Pharmaceuticals USA, Inc recalls Isotretinoin Capsules, USP, 30 mg, Rx Only, 10 count Prescription Pack, Manufactured for: Teva Pharmaceuticals USA, Inc…

Recall date
January 12, 2026
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
D-0445-2026
FDA classification
Class II
Brand / firm
Teva Pharmaceuticals USA, Inc
Sold / distributed
FL, OH, PR & MS

Why it was recalled

Superpotent and Subpotent

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Isotretinoin Capsules, USP, 30 mg, Rx Only, 10 count Prescription Pack, Manufactured for: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0591-2435-15 (carton), NDC 0591-2435-45 (blister pack).

Get recall alerts

Free email alert whenever Teva Pharmaceuticals USA, Inc has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Teva Pharmaceuticals USA, Inc